Table 1.
Characteristics | Results [N = 50] |
---|---|
Age at start of treatment, years [median (range)] | 59 (35–75) |
Male sex | 27 (54) |
Clinical tumor category | |
T2N0 | 0 (0) |
T2N1 | 4 (8) |
T3N0 | 6 (12) |
T3N1-2 | 32 (64) |
T4N0 | 1 (2) |
T4N1-2 | 7 (14) |
Metastatic site | |
Liver | 42 (84) |
Lung | 5 (10) |
Lung and liver | 3 (6) |
Liver metastases | |
1–3 | 36 (72) |
>3 | 9 (18) |
Lung metastases | |
1 | 5 (10) |
>1 | 3 (6) |
Radiotherapy | |
Patients completing radiotherapy | 50 (100) |
Interval between completion of RT and start of CT—days | |
Median (range) | 11 (3–44) |
Chemotherapy | |
Patients receiving six cycles | 42 (84) |
Surgery | |
Radical surgical treatment | 36 (72) |
Sequence of surgery | |
Simultaneous resection | 25 (50.0) |
Primary first | 10 (20) |
Metastases first | 5 (10) |
Data are expressed as n (%) unless otherwise specified
RT radiotherapy, CT chemotherapy